| 1. THE CHEMORADIOTHERAPY OF HIGH RISK VALVAR CARCINOMA |
Page:— |
| 2. RELATIONSHIP BETWEEN DEGREE OF INVASION AND TUMOR METASTASIS |
Page:— |
| 3. THE EFFECTS OF DIBUTYL PHTHALATE ON THE PROLIFERATION AND APOPTOSIS OF LEUKEMIC CELLS FROM ACUTE LEUKEMIA |
Page:— |
| 4. COMBINED CHEMOTHERAPY OF LATE MALIGNANT TUMORS WITH HIGH-DOSE CALCIUM LEUCO-VORIN (CF) AND 5-FLUOROURACIL (5-FU) |
Page:— |
| 5. THE METHYLATION OF p53 GENE IN THYROID CARCINOMA |
Page:— |
| 6. THE TREATMENT OF TESTICLE EMBRYONAL RHABDOMYOSARCOMA |
Page:— |
| 7. A STUDY ON THE RELATIONSHIP BETWEEN EXPRESSION OF CD44 ADHESION MOLECULES AND TU-MOR METASTASIS |
Page:— |
| 8. bcr_3/abl_2 ANTISENSE OLIGODEOXYNUCLEOTIDE INDUCES APOPTOSIS IN CHRONIC MYELOID LEUKEMIA |
Page:— |
| 9. THERAPY FOR LIVER METASTASIS OF COLORECTAL CARCINOMAS |
Page:— |
| 10. A STUDY ON THE SCREENING OF LARGE INTESTINAL CARCINOMA BY T-ANTIGEN MONOCLONAL AN-TIBODY METHOD |
Page:— |
| 11. SYNCHRONOUS MULTIPLE PRIMARY CANCER AND ADENOMA OF LARGE INTESTINES |
Page:— |
| 12. THREE-DIMENSIONAL MORPHOLOGY OF HEPATOCELLULAR CARCINOMA——THE APPLICATION OF CONFOCAL LASER SCANNING MICROSCOPY IN TUMOR PATHOLOGY |
Page:— |
| 13. THE INFLUENCE OF p53 GENE IN 5-FLUOROURACIL (5-FU) INDUCED APOPTOSIS OF COLORECTAL CANCER |
Page:— |
| 14. Therapeutic effect of rhG-CSF on grade Ⅳ leukopenia induced by chemotherapy of malignant tumor |
Page:— |
| 15. Adervances in the research of multidrug resistance-associated protein's biological characters and mechanism |
Page:— |
| 16. Advances of the research on the correlation of nitric oxide and the generation,development and metastasis of tumors |
Page:— |
| 17. Advances of gemcitabin in non-small-cell lung cancer |
Page:— |
| 18. Preservation of cervical plexus in the functional neck dissection of differentiated thyroid cancer |
Page:— |
| 19. Surgical treatment of substernal benign thyroid tumor |
Page:— |
| 20. High-dose epirubicin combination therapy in the treatment of 48 cases with advanced chest malignant tumors |
Page:— |
| 21. Application of rhG-CSF in children's acute leukemia |
Page:— |
| 22. Surgical treatment of esophageal and cardiac cancer in elderly patients |
Page:— |
| 23. Quantitative study on PCNA, AgNOR, DNA content and nuclear morphometry of colorectal cancer |
Page:— |
| 24. Vinorelbine plus cisplatin in the treatment of 48 cases with advanced non-small-cell lung cancer |
Page:— |
| 25. Comparison of the therapeutic effect of several drugs infused into the bladder for superficial tumors after transurethral resection of the bladder tumor |
Page:— |
| 26. Antitumor effects of CIK cells against hepatocellular carcinoma cells in vitro and in vivo |
Page:— |
| 27. Retrospective analysis of patients with survival of over ten years after resection of esophageal cancer |
Page:— |
| 28. Paclitaxel plus carboplatin or cisplatin for patients with advanccd head and ncck cancer |
Page:— |
| 29. Analysis of indications for adjuvant treatment in node-negative breast cancer |
Page:— |
| 30. Expression of p27~(Kip1) and cyclin D1 in human gastric carcinoma and its prognostic significance |
Page:— |
| 31. Expressions of MDR and GST-? related to the response of neoadjuvant chemotherapy and prognosis in cervical cancer |
Page:— |
| 32. Expression of human vascular endothelial growth factor in ampullary carcinoma and its significance |
Page:— |
| 33. Construction of antisense VEGF eukaryotic expression vector and effect to ovarian cancer cell |
Page:— |
| 34. Combined chemotherapy with gemicitabine and cisplatin as preoperative induction treatment in patients of stage m a( N_2) NSCLC |
Page:— |
| 35. Chemokine and breast cancer metastasis |
Page:— |
| 36. Analysis of causes and management of bronchus-pleural fistula after pneumonectomy of lung cancer |
Page:— |
| 37. 3-D conformal radiotherapy for malignant thoracic tumors |
Page:— |
| 38. Randomized study of low molecular weight heparin (LMWH) plus chemtherapy in advanced non-small cell lung cancer |
Page:— |
| 39. Evaluation on the antiemetic effect of azasetron hydrochloride in patients with liver neoplasm after transcatheter arterial chemoembolization |
Page:— |
| 40. Evaluation of urinary NMP_(22) in the detection of transitional cell carcinoma of bladder |
Page:— |
| 41. Erythropoietin therapy for anemic patients with non-small cell lung cancer in combination chemotherapy |
Page:— |
| 42. The influence of aspirin on apoptosis and Fas/FasL expression of Caco-2 cell |
Page:— |
| 43. Application of compartment resection in patients with extremity soft tissue sarcomas |
Page:— |
| 44. Relationship between the effect of docetaxel inducing apoptosis of non - small - cell lung cancer cell and the intracellular level of reactive oxygen |
Page:— |
| 45. Differential diagnostic usefulness of CK19, S-100 protein and EMA in papillary carcinoma and papillary hyperplasia |
Page:— |
| 46. Papillary carcinoma in a thyroglossal duct remnant |
Page:— |
| 47. Expression of vascular endothelial growth factors VEGF, VEGF-C and flt-4 in breast cancer and its clinical pathological analysis |
Page:— |
| 48. The effect of persortality on the mental adjustment of breast cancer patients during operation |
Page:— |
| 49. Utility of computer -aided detection in the diagnosis of breast carcinoma with mammography |
Page:— |
| 50. Identifying factors related to bone metastasis in breast cancer |
Page:— |
| 51. Character of drug targeting lymph nodes after regional injection of carboplatin-activated carbon in patients with breast cancer |
Page:— |
| 52. The combination of navelbine and epirubicin as neoadjuvant chemotherapy in the treatment of locally advanced breast cancer |
Page:— |
| 53. Influence of estrogen on the proliferation of MCF7, a human breast carcinoma cell line |
Page:— |
| 54. Prognostic and predictive factors in lymph node negative breast cancer and establishment of mathematical model |
Page:— |
| 55. Detection of CK-19 mRNA in peripheral blood from breast cancer patients by reverse transcription polymerase chain reaction |
Page:— |
| 56. Clinical significance of the circulating chemokines in breast carcinoma patients |
Page:— |
| 57. Current status and advances in adjuvant therapy of operable breast cancer |
Page:— |
| 58. New advances of taxol in clinical application of breast cancer |
Page:— |
| 59. Regulation of tumor suppressor gene methylation in human gastric cancer |
Page:— |
| 60. Progress of selecting tumor markers using SELDI ProteinChip technique |
Page:— |
| 61. Research advances in uterine papillary serous carcinoma |
Page:— |
| 62. Developments in the chemotherapy treatment for advanced colorectal cancer |
Page:— |
| 63. Venorelbine combined with fluorouracil/leucovorin in patients with nasopharyngeal carcinoma refractory to platinum based chemotherapy |
Page:— |
| 64. Vinorelbine plus oxaliplatin in the treatment of advanced non-small-cell lung cancer |
Page:— |
| 65. Gemcitabine and carboplatin combination chemotherapy for 27 cases of advanced non-small-cell lung cancer |
Page:— |
| 66. Analysis of the reasons for postoperative complications and death of thoracic tumors |
Page:— |
| 67. Detection of serum vascular endothelial growth factor level before radiotherapy in cancer patients and its clinical significance |
Page:— |
| 68. Synergistic anti-cancer effects and mechanisms of huachansu plus vinorelbine on Lewis lung cancer cell in mice |
Page:— |
| 69. Paclitacxel and carboplatin in advanced non-small-cell lung cancer |
Page:— |
| 70. Regulative effect of arsenic trioxide on the drug-resistant protein in MR_2 cell lines |
Page:— |
| 71. Vinorelbine combined with capecitabine in the treatment of advanced and metastatic breast cancer |
Page:— |
| 72. Clinical diagnosis,treatment and prognosis stuty of 22 cases of meningeal metastasis |
Page:— |
| 73. Three platinum-based regimens to treat patients with advanced NSCLC:a clinical investigation |
Page:— |
| 74. Treatment of advanced and metastatic colorectal cancer with combined chemotherapy based on oxaliplatin,irinotecan and fluorouracil |
Page:— |
| 75. Docetaxel administered as three consecutive weekly infusions plus cisplatin for advanced non-small-cell lung cancer |
Page:— |
| 76. Effect of doses of three-dimensional conformal radiotherapy for unresectable biliary cancer |
Page:— |
| 77. Short-term efficacy of combination of MabThera and CEOP regimen in the treatment of aggressive B-cell lymphoma |
Page:— |
| 78. CT and MRI evaluation of peripheral primitive neuroectodermal tumors |
Page:— |
| 79. Feasibility of ~1H-MRS in the DEN induced rat hepatocellular carcinoma by a new 1.5T MR scanner |
Page:— |
| 80. HER-2/neu gene amplification and expression in nasopharyngeal carcinoma and their clinical significance |
Page:— |
| 81. Expression and clinical significance of tGF-?1,Cyclin E in gallbladder carcinoma |
Page:— |
| 82. Detection of cytokeratin 19 (CK19) mRNA and human papillomavirus type 16 (HPV16) mRNA in peripheral blood of cervical cancer patients and its significance |
Page:— |
| 83. Effect of 1,2:5,6-dianhydro-3,4-diacetylgalactitol and p53 gene transfection for the growth of hepatocellular carcinoma |
Page:— |
| 84. Investigations of synchronization of expression between apoptosis and P27~(Kip1),PCNA in esophagus squamous cell carcinoma |
Page:— |
| 85. Rho family expression in neoplasms and its clinical significance |
Page:— |
| 86. Advance in reseach on the diagnosis for pancreatic carcinoma by spiral CT |
Page:— |
| 87. Detection of CK19 mRNA and CK20 mRNA in peripheral blood cells of patients with early cervicalcancer and its clinical significance |
Page:— |
| 88. Three-dimensional conformal radiation therapy plus arterial iufusion chemotherapy for pancreatic cancer |
Page:— |
| 89. Clinicopathological characritics and prognosis of large intestinal mucoid adenocarcinoma |
Page:— |
| 90. Percutaneous portal vein chemoembolization in the treatment of primary hepatic carcinoma with portal veintumor thrombus |
Page:— |
| 91. Therapeutic effects of 3-dimensional conformal radiotherapy(3D-CRT) and concurrent chemotherapy in advanced non-small-cell lung cancer(NSCLC) |
Page:— |
| 92. Surgical treatment of 15 tracheoesophageal fistulas secondary to carcinoma of esophagus after radiotherapy |
Page:— |
| 93. Prognostic factors of 152 cases with Ⅲ/Ⅳ stage nasopharyngeal carcinoma |
Page:— |
| 94. Bone scan characteric findings for hypertrophic pulmonary osteoarthropathy (HPO) in patients with pulmonary diseases |
Page:— |
| 95. Treatment evaluation of hepatectomy and chemotherapy for primary liver cancer |
Page:— |
| 96. Role of telomere, telomerase and hTERT in colorectal carcinoma |
Page:— |
| 97. Measurement of serum and urine TGF?1 level in bladder cancer patients and its clinical significance |
Page:— |
| 98. Effects of artesunate on the proliferation and apoptosis of gastric carcinoma cells |
Page:— |
| 99. Relationship between the expression levels of cell cycle regulators and the proliferation ability of human giant-cell lung carcinoma cell strains 95C and 95D |
Page:— |
| 100. Relationship between polymorphisms of DNA repair gene XRCC1 and susceptibility to lung cancer |
Page:— |
| 101. Expression of midkine protein in non-small-cell lung cancer and its clinical significance |
Page:— |
| 102. Anti-invasion and anti-metastasis effects of ginsenoside Rg3 on the hepatocellUlar carcinoma cell line |
Page:— |
| 103. Aberrant expression of B7-H4 and BTLA in tumormodel |
Page:— |
| 104. CEA DNA vaccine induces special cellular and humoral immune response to a carcinoembryonic antigen in mice |
Page:— |
| 105. Continuous infusion of paclitaxel combined with cisplatin in the treatment of advanced non-small-cell lung cancer |
Page:— |
| 106. The Primary of single photonemisson computed tomography in diagnosis of multifical pulmonary lesions |
Page:— |
| 107. Clinicopathological significance of vascular endothelial growth factor C and its receptors in cervical carcinoma |
Page:— |
| 108. Concurrent chemoradiotherapy with low dose weekly paclitaxel in the treatment of stage Ⅲ non-small-cell lung cancer |
Page:— |
| 109. Effects of mifepristone on the growth of human endometrial carcinoma cell line HHUA xenografted in nude mice of and the expressions of COX-2,CDK4 |
Page:— |
| 110. Postoperative radiotherapy of head and neck squamous cell cancer |
Page:— |
| 111. Combination of CPT-11 and capecitabine in the treatment of advanced gastric cancer |
Page:— |
| 112. Concurrent PCF chemotherapy plus radiotherapy for middle and advanced cervical cancer |
Page:— |
| 113. Effect of NK-104 on NF-?B activated by TNF-? in hepatocellular carcinoma cells |
Page:— |
| 114. Rab27A is involved in malignant phenotypes in human breast cancer cells by regulating the expression of related genes |
Page:— |
| 115. Establishment and characterization of a docetaxel-resistant variant of human lung adenocarcinoma cell line SPC-A1 |
Page:— |
| 116. RNA interference mediated inhibition of epidermal growth factor receptor expression and its significance in different human cancer cell lines |
Page:— |
| 117. Research avancement of breast cancer and hypoxia-inducible factor-1 |
Page:— |
| 118. The research progress of carcino-embryonic antigen related cellular adhesion molecule 1 |
Page:— |
| 119. Combined measurement of serum CYFRA21-1,NSE,CEA,CA19-9,CA125 and SCC:diagnosis value to lung cancer |
Page:— |
| 120. The clinicopathologic characters and prognosis of cervical cancer in 831 young women under 35 years old |
Page:— |
| 121. Expression of vWF and integrin?_3 in H460 cells and association between the two factors and tumor metastasis |
Page:— |
| 122. Effect of combination of TRAIL and paclitaxel on human gastric cancer cell line SGC7901 |
Page:— |
| 123. Gene expression of tyrosine kinase receptor pathway in primary glioblastoma and its significance |
Page:— |
| 124. Expression of CD4~+CD25~+ regulatory T cells in colorectal cancer patients and its significance |
Page:— |
| 125. Effect of CD133~+ stem cells from cord blood on the proliferation,adhesion and migration in human colorectal neoplasm cell line SW480 |
Page:— |
| 126. The current treatment for brain metastases from breast cancer |
Page:— |
| 127. Advances on LKB1 in the study of lung cancer |
Page:— |
| 128. The value of bile CEA assay in detection of liver metastasis in patients with colorectal cancer |
Page:— |
| 129. Relation of expression of survivin and BCRP gene in prediction of response to chemotherapy in metastatic breast cancer |
Page:— |
| 130. Clinical observation of temozolomide combined with radiotherapy for 18 cases of newly diagnosed high grade gliomas |
Page:— |
| 131. Hydroxycamptothecine plus oxaliplatin compared with fluorouracil/leucovorin (LV5FU2) plus oxaliplatin in the treatment of metastatic colorectal cancer:a randomized clinical study |
Page:— |
| 132. An evaluation on effect and safety of morphine sulfate controlled-release tablet combined with celecoxib for the treatment of moderate to severe cancer-induced pain |
Page:— |
| 133. Change expressing of hTERT gene in breast cancer tissue before and after neo-adjuvant chemotherapy |
Page:— |
| 134. Comparative clinical study on preoperative intra-arterial infusion chemotherapy for advanced gastric cancer |
Page:— |
| 135. Research progress on target therapy in advanced non-small cell lung cancer |
Page:— |
| 136. Molecular imaging probes for integrin ?_V?_3 |
Page:— |
| 137. Research progresses on relationship between Wnt inhibitory factor-1 and tumor |
Page:— |
| 138. Evaluation of the following treatment after cervical conization with positive margins for patients with cervical neoplasm |
Page:— |
| 139. Late course accelerated hyperfractionation radiotherapy combined with chemotherapy for elderly patients with esophageal carcinoma |
Page:— |
| 140. The clinical efficacy of capecitabine administrated continuously for three weeks in treating old patients with advanced digestive tract cancer |
Page:— |
| 141. Inhibition of STAT3 expression on chemosensitivity of ovarian cancer cell line SKOV3 |
Page:— |
| 142. Suppression of human glioblastoma in nude mice by siRNA Notch-1 gene therapy |
Page:— |
| 143. Genetic polymorphisms of methionine synthase,methylation of CHD5,and their association with breast cancer mobidity |
Page:— |
| 144. Construction and expression of anti-CD3?anti-CD19 bispecific diabody and analyzing its specific binding activity |
Page:— |
| 145. CLINICAL ANALYSIS FOR 148 CASES OF COLORECTAL ADENOMA WITH MALIGNANT CHANGE |
Page:— |
| 146. Cyclins/CDKs and antitumor activity of their inhibitors |
Page:— |
| 147. The activated endothelial cells serve as target in tumor treatment |
Page:— |
| 148. Advances in the research on the STK11 gene |
Page:— |
| 149. Clinical analysis of 16 cases with olfactory neuroblastoma |
Page:— |
| 150. Management of chylothorax after pulmonary resection |
Page:— |
| 151. The toxic reactions of all-trans retinoic acid occuring in the treatment of acute promyelocytic leukemia |
Page:— |
| 152. Hypoxia-induced apoptosis and anti-apoptosis in ovarian cancer cell line SKOV-3ipl cells and its correlation with cell cycle |
Page:— |
| 153. Evaluation of intravenous and intraperitoneal chemotherapy in advanced gastric cancer |
Page:— |
| 154. Clinical analysis of preoperative diagnostic methods in small sized lung cancer (≤3 cm) |
Page:— |
| 155. Expression of telomerase activity in peripheral blood of patients with lung cancer |
Page:— |
| 156. The diagnosis and treatment of urachal carcinoma(Report of three cases and literature review) |
Page:— |
| 157. Genetic diagnosis of occult metastasis of lymph node in patients with esophageal carcinoma |
Page:— |
| 158. Effect of peripheral blood lymphocyte subsets and prognosis in autologous LAK cell treatment of advanced lung adenocarcinoma |
Page:— |
| 159. Expression of uPA,uPAR,PAI-1 in three nasopharyngeal carcinoma cell(NPC) lines with different ability to metastasize |
Page:— |
| 160. The patterns of cervical lymph node metastatic squamous cell carcinoma from different primary sites of head and neck cancers |
Page:— |
| 161. Hepatoid adenocarcinoma of the stomach: report of 3 cases and review of the literature in recent ten years |
Page:— |
| 162. The expression of PS2 protein in breast cancer and it's clinical significance |
Page:— |
| 163. Contrast analysis of breast cancer and benign lesion with FCM |
Page:— |
| 164. Expression of P16 and P15 in human gastric carcinoma and metastatic lymph node |
Page:— |
| 165. Expression of NF-Kappa B and human telomerase reverse transcriptase in gastric carcinogenesis |
Page:— |
| 166. Relationship between cell apoptosis and dephosphorylated RB protein in human breast cancer |
Page:— |
| 167. The cytotoxic effect,cell cycle perturbations and apoptosis of paclitaxel in human bladder cancer lines |
Page:— |
